Novel Medical Therapeutics Inc
Novel Medical Therapeutics Inc, based in Twinsburg, OH, is pioneering innovative therapies targeting complement-mediated rare diseases, including groundbreaking treatments for conditions such as wet and dry age-related macular degeneration and paroxysmal nocturnal hemoglobinuria. The company is advancing its lead candidates, NM8074 and NM5072, through Phase II clinical trials, demonstrating promising results and a commitment to addressing unmet medical needs.
With a robust pipeline of antibody therapies and a unique approach that selectively targets the Alternative Pathway, NovelMed aims to minimize side effects while maintaining the body's defense against infections. The company is actively pursuing partnerships, investments, and acquisition opportunities to further enhance its position in the rare disease market, which is estimated to exceed $400 billion.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
